
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.520 | 1.520 | 0.000 |
Stocks | 98.480 | 98.480 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.399 | 20.375 |
Price to Book | 3.827 | 4.159 |
Price to Sales | 1.664 | 2.501 |
Price to Cash Flow | 16.420 | 16.685 |
Dividend Yield | 1.624 | 1.352 |
5 Years Earnings Growth | 10.687 | 12.022 |
Number of long holdings: 53
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.45 | 507.6 | -4.32% | |
Eli Lilly | US5324571083 | 6.16 | 821.86 | -0.27% | |
J&J | US4781601046 | 6.13 | 162.85 | -1.81% | |
AstraZeneca | GB0009895292 | 6.10 | 11,650.0 | +1.48% | |
Roche Holding Participation | CH0012032048 | 5.56 | 307.30 | +3.64% | |
Thermo Fisher Scientific | US8835561023 | 3.89 | 512.65 | -0.30% | |
Lonza Group | CH0013841017 | 3.72 | 539.20 | +0.97% | |
UnitedHealth | US91324P1021 | 3.59 | 481.11 | -1.01% | |
Pfizer | US7170811035 | 2.94 | 25.71 | -1.08% | |
AbbVie | US00287Y1091 | 2.71 | 212.06 | -0.72% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNB Global indeks NOK | 113.65B | 0.62 | 19.20 | 13.91 | ||
DNB Teknologi NOK | 76.83B | 40.12 | 21.87 | 22.47 | ||
Pensjonsprofil 80 | 50.58B | 3.55 | 8.48 | 9.02 | ||
DNB Global IV | 39.85B | 28.37 | 16.18 | 14.68 | ||
Pensjonsprofil 50 | 28.22B | 2.52 | 6.07 | 6.66 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review